上海交大昂立股份有限公司2025年年度业绩预减公告

Core Viewpoint - Shanghai Jiaotong University Anli Co., Ltd. expects a significant decline in its 2025 annual net profit, projecting a decrease of approximately 85% compared to the previous year, primarily due to reduced revenue in its health products segment and losses from its investment subsidiary [2][3]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of approximately 4.5 million yuan for 2025, a decrease of about 25.98 million yuan year-on-year [2]. - The expected net profit after deducting non-recurring gains and losses is projected to be -7 million yuan, reflecting a year-on-year decline of approximately 220% [2]. - Estimated operating revenue for 2025 is around 314.7 million yuan, with core operating revenue (excluding unrelated business income) expected to be approximately 314.07 million yuan [2]. Group 2: Previous Year Performance - In the previous year, the total profit was 38.99 million yuan, with a net profit attributable to shareholders of 30.48 million yuan and a net profit after deducting non-recurring gains and losses of 5.82 million yuan [3]. - The earnings per share for the previous year were 0.04 yuan [3]. Group 3: Reasons for Performance Decline - The decline in net profit is attributed to decreased revenue in the health products segment compared to the previous year [3]. - Losses from the investment subsidiary have also contributed to the decline in net profit [3].